x
Vaccines & Immunology open Access Journal
Vaccines & Immunology open Access Journal

Journal Short Name - VIOAJ

Vaccines & Immunology open Access Journal

Aims & Scope

 

Vaccines & Immunology open Access Journal is a peer reviewed, online, international, open access journal which encompassing aspects of research on all phases of immunology and in the research of Vaccines. The Journal is rapidly available, and easy to get globally through internet for scholarly development in the field. Vaccines & Immunology open Access Journal is dedicated to publishing and disseminating all update and top-tier original research articles, letters, case reports, reviews, letters, editorials and short communications etc. in all areas of vaccines and immunology.

 

Animal models for immunologic diseases

Cancer Vaccines

Chicken pox Vaccines

Childhood Vaccines

Component Vaccines

Ebola Vaccines

HIV Vaccines Research & Development

Human Papilloma Virus Vaccine

Immune responses to vaccines

Immunology mechanisms

Immunopathogenesis

Immunotherapeutic

MMR Vaccines

Polio Vaccines

Preclinical Vaccine Studies

Prophylactic vaccines

Recombinant Vector Vaccines

Therapeutic vaccines

Tuberculosis Vaccines

Vaccination

Vaccine

Vaccine Adjuvants

Vaccine development and efficacy evaluation

Vaccine Regulatory Issues

Vaccine Research & Development

Vaccine technology

Vaccine vectors, adjuvants and immunomodulators

Vaccines Dermatology

Vaccines Epidemiology

Vaccines Immunology

Veterinary Vaccines

Viral immunology

 

The articles can be accessed online immediately on their publication. We are committed to providing authors with a rapid, fair, and constructive external peer-review process, with the goal of providing the majority of first decisions within 2 weeks.

 

All submissions are peer reviewed. If accepted for publication, authors are requested to pay an article processing fee per article. Following payment of this fee, the article will be made universally available.

 

We look forward to receiving your contribution.

 

Signup to recive email updatesx